- Filed
- Aug 10, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Aug 10, 2021 | 14.01M sh |
| Cash And Equivalents | Q3 2021 · Mar 31, 2021 | $317.09K |
| Cash And Equivalents | Q3 2021 · Jun 30, 2020 | $4.27M |
| Total Liabilities | Q3 2021 · Mar 31, 2021 | $591.16K |
| Total Liabilities | Q3 2021 · Jun 30, 2020 | $4.37M |
| Current Assets | Q3 2021 · Mar 31, 2021 | $12.73M |
| Current Assets | Q3 2021 · Jun 30, 2020 | $4.28M |
| Total Assets | Q3 2021 · Mar 31, 2021 | $12.81M |
| Total Assets | Q3 2021 · Jun 30, 2020 | $4.28M |
| Operating Cash Flow restated | Q3 2021 · Mar 31, 2020 | −$21.08K |
| Stockholders Equity | Q3 2021 · Mar 31, 2020 | −$44.22K |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | −$15.92K |
| Stockholders Equity | Q3 2021 · Jun 30, 2019 | $1.47K |
| Sga Expense | Q3 2021 · Mar 31, 2020 | $858 |
| Sga Expense | Q3 2021 · Mar 31, 2020 | $995 |
| Net Income | Q3 2021 · Mar 31, 2020 | −$28.3K |
| Net Income | Q3 2021 · Mar 31, 2020 | −$45.69K |
| Operating Income | Q3 2021 · Mar 31, 2020 | −$28.3K |
| Operating Income | Q3 2021 · Mar 31, 2020 | −$45.69K |